- Home
- NPCT
as 07-26-2024 4:00pm EST
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 320.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 107.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $8.58 - $10.63 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Nuveen Core Plus Impact Fund of Beneficial Interest (NPCT)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | NPCT | 10% Owner | May 9 '24 | Buy | $10.39 | 22,623 | $235,052.97 | 3,423,331 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | May 6 '24 | Buy | $10.32 | 48,288 | $498,332.16 | 3,400,708 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Apr 29 '24 | Buy | $10.10 | 19,191 | $193,829.10 | 3,352,378 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Apr 25 '24 | Buy | $10.03 | 68,072 | $682,762.16 | 3,333,187 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Apr 3 '24 | Buy | $10.29 | 28,324 | $291,453.96 | 3,265,115 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Apr 2 '24 | Buy | $10.26 | 30,848 | $316,500.48 | 3,236,791 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Mar 19 '24 | Buy | $10.28 | 13,886 | $142,748.08 | 3,205,943 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Mar 13 '24 | Buy | $10.36 | 100 | $1,036.00 | 3,192,057 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Mar 11 '24 | Buy | $10.34 | 9,650 | $99,781.00 | 3,188,901 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Mar 11 '24 | Buy | $10.34 | 3,056 | $31,599.04 | 3,191,957 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Mar 7 '24 | Buy | $10.31 | 53,622 | $552,842.82 | 3,032,785 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Mar 7 '24 | Buy | $10.33 | 146,466 | $1,512,993.78 | 3,179,251 | SEC Form 4 |
| Saba Capital Management, L.P. | NPCT | 10% Owner | Dec 18 '23 | Buy | $10.11 | 25,106 | $253,821.66 | 2,979,163 | SEC Form 4 |
Latest Nuveen Core Plus Impact Fund of Beneficial Interest News
NPCT Breaking Stock News: Dive into NPCT Ticker-Specific Updates for Smart Investing
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Business Wire
2 months ago
Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
AFP
2 months ago
New Zealand scraps plan to tax livestock burps, farts
The Wall Street Journal
2 months ago
ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
Business Wire
2 months ago
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
Bloomberg
2 months ago
UK Unemployment Rises in Sign Inflationary Pressures Cool
Simply Wall St.
2 months ago
Insider-Owned Growth Companies On The Chinese Exchange In June 2024
Compare NPCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NPCT Nuveen Core Plus Impact Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.